SCHEMBL564823

SCHEMBL564823

B1OCc2ccccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31276751 0.76 CA12 (0.35)
SCHEMBL13637265 0.69 PBRM1 (0.34)
SCHEMBL19095465 0.67 MAOA (0.30)
SCHEMBL10268397 0.64 DRD2 (0.31)
SCHEMBL23004794 0.62 MAOA (0.39)
SCHEMBL59871 0.60
SCHEMBL30473446 0.60 TSHR (0.42)
SCHEMBL4486486 0.60 TSHR (0.42)
SCHEMBL29471383 0.60
SCHEMBL13371771 0.60 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4694932-A2 COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS Protomer Technologies Inc. (US) 2026-02-18 EP claimed
WO-2024215876-A2 COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS PROTOMER TECHNOLOGIES, INC. (US) 2024-10-17 WO claimed
CN-1155286-A Oxaboroles and salts thereof, and thire use as biocides ZENECA LTD (GB) 1997-07-23 CN claimed
EP-0765331-A1 OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES ZENECA LIMITED (GB) 1997-04-02 EP claimed
WO-1995033754-A1 OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES ZENECA LIMITED (GB) 1995-12-14 WO claimed
US-20260076967-A1 HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER TOLREMO THERAPEUTICS AG (CH) 2026-03-19 US disclosed
EP-4694932-A2 COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS Protomer Technologies Inc. (US) 2026-02-18 EP disclosed
US-20260000777-A1 NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF ARARIS BIOTECH AG (CH) 2026-01-01 US disclosed
US-12478624-B2 Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer TOLREMO THERAPEUTICS AG (CH) 2025-11-25 US disclosed
US-12364768-B2 Nectin-4 antibody conjugates and uses thereof ARARIS BIOTECH AG (CH) 2025-07-22 US disclosed
CN-119630642-A Compounds for the treatment of coronavirus infections 特劳斯芬尼德治疗股份有限公司 2025-03-14 CN disclosed
CN-119604290-A Compounds for the treatment of coronavirus infections 特劳斯芬尼德治疗股份有限公司 2025-03-11 CN disclosed
WO-2013050591-A2 METHOD FOR PROTECTING USEFUL PLANTS OR PLANT PROPAGATION MATERIAL SYNGENTA PARTICIPATIONS AG (CH) 2013-04-11 WO disclosed
US-20120035132-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2012-02-09 US disclosed
CN-1068005-C Oxaboroles and salts thereof, and thire use as biocides ZENECA LTD (GB) 2001-07-04 CN disclosed
EP-0765331-B1 OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES AVECIA LTD (GB) 2000-08-09 EP disclosed
US-5880188-A PROTECTING MEDIUM SUSCEPTIBLE TO MICROBIAL ATTACK BY TREATING WITH SPECIFIED OXABOROLE COMPOUND ZENECA LIMITED (GB) 1999-03-09 US disclosed
CN-1155286-A Oxaboroles and salts thereof, and thire use as biocides ZENECA LTD (GB) 1997-07-23 CN disclosed
EP-0765331-A1 OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES ZENECA LIMITED (GB) 1997-04-02 EP disclosed
WO-1995033754-A1 OXABOROLES AND SALTS THEREOF, AND THEIR USE AS BIOCIDES ZENECA LIMITED (GB) 1995-12-14 WO disclosed